NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email /PRNewswire/ — IBM (NYSE: IBM) and the EY organization continue to build upon their multiyear alliance, today announcing the availability of EY.ai for tax,…Read More